BioMerieux Net Change in Intangible Assets 2017-2024 | BMXMF
BioMerieux annual/quarterly net change in intangible assets history and growth rate from 2017 to 2024. Net change in intangible assets can be defined as the overall change from the sale and purchase of intangible assets including patents, rights and capitalized software.
- BioMerieux net change in intangible assets for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
- BioMerieux net change in intangible assets for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
- BioMerieux annual net change in intangible assets for 2024 was $0B, a 0% decline from 2023.
- BioMerieux annual net change in intangible assets for 2023 was $0B, a 0% decline from 2022.
- BioMerieux annual net change in intangible assets for 2022 was $0B, a 0% decline from 2021.
| BioMerieux Annual Net Change in Intangible Assets (Millions of US $) |
|
|---|---|
| 2024 | $N/A |
| 2023 | $N/A |
| 2022 | $N/A |
| 2021 | $N/A |
| 2020 | $N/A |
| 2019 | $N/A |
| 2018 | $N/A |
| 2017 | $N/A |
| 2016 | $N/A |
| 2015 | $N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $17.547B | $4.307B |
| bioM?rieux S.A. designs, develops, manufactures and markets systems in the field of vitro diagnostics. The company provides diagnostic solutions which determine the source of disease and contamination. It also offers solutions for managing infectious diseases, cancers and cardiovascular diseases in clinical applications. The company provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for the agri-food, cosmetics and pharmaceutical industries. bioM?rieux S.A. is based in Marcy L Etoile, France. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.003B | 27.08 |
| CVS Health (CVS) | United States | $90.597B | 11.27 |
| Elevance Health (ELV) | United States | $69.715B | 9.38 |
| Cencora (COR) | United States | $58.790B | 19.58 |
| DiDi Global (DIDIY) | China | $29.369B | 31.20 |
| Labcorp Holdings (LH) | United States | $22.982B | 18.27 |
| Natera (NTRA) | United States | $22.227B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.490B | 0.00 |
| ICON (ICLR) | Ireland | $14.189B | 13.65 |
| Medpace Holdings (MEDP) | United States | $12.736B | 33.71 |
| CochLear (CHEOY) | Australia | $12.699B | 0.00 |
| Solventum (SOLV) | United States | $12.484B | 12.88 |
| Viatris (VTRS) | United States | $12.463B | 4.44 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.720B | 0.00 |
| Revvity (RVTY) | United States | $10.408B | 18.34 |
| Avantor (AVTR) | United States | $8.563B | 12.56 |
| Sonic Healthcare (SKHHY) | Australia | $7.992B | 0.00 |
| HealthEquity (HQY) | United States | $7.874B | 34.49 |
| Charles River Laboratories (CRL) | United States | $7.606B | 14.43 |
| Bausch + Lomb (BLCO) | Canada | $5.133B | 34.52 |
| Sotera Health (SHC) | United States | $4.525B | 25.29 |
| BrightSpring Health Services (BTSG) | United States | $4.244B | 32.38 |
| KindlyMD (NAKA) | United States | $3.998B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.468B | 79.42 |
| Alignment Healthcare (ALHC) | United States | $3.129B | 0.00 |
| Concentras Parent (CON) | United States | $2.949B | 18.71 |
| Surgery Partners (SGRY) | United States | $2.931B | 36.87 |
| Organon (OGN) | United States | $2.412B | 2.63 |
| Premier (PINC) | United States | $2.106B | 19.53 |
| Progyny (PGNY) | United States | $1.989B | 42.06 |
| Ardent Health (ARDT) | United States | $1.826B | 7.05 |
| PACS (PACS) | United States | $1.788B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.560B | 26.41 |
| Pediatrix Medical (MD) | United States | $1.406B | 9.39 |
| Teladoc Health (TDOC) | United States | $1.270B | 0.00 |
| Omada Health (OMDA) | $1.236B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.159B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.809B | 4.74 |
| AMN Healthcare Services Inc (AMN) | United States | $0.753B | 9.31 |
| CareDx (CDNA) | United States | $0.666B | 12.27 |
| QDM (QDMI) | Hong Kong, SAR China | $0.641B | 110.00 |
| Performant Healthcare (PHLT) | United States | $0.602B | 0.00 |
| Nutex Health (NUTX) | United States | $0.534B | 8.09 |
| Agilon Health (AGL) | United States | $0.510B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.484B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.466B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.465B | 6.98 |
| SBC Medicals (SBC) | United States | $0.438B | 9.61 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.414B | 0.00 |
| Enhabit (EHAB) | United States | $0.405B | 26.63 |
| So-Young (SY) | China | $0.395B | 0.00 |
| Oncology Institute (TOI) | United States | $0.329B | 0.00 |
| LifeMD (LFMD) | United States | $0.298B | 0.00 |
| Beauty Health (SKIN) | United States | $0.263B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.186B | 0.00 |
| DocGo (DCGO) | United States | $0.156B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.135B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.090B | 0.00 |
| Biodesix (BDSX) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.051B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.035B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| OSR Holdings (OSRH) | United States | $0.010B | 0.00 |
| ModivCare (MODV) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| INVO Fertility (IVF) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |